Profile data is unavailable for this security.
About the company
Inmode Ltd is an Israel-based company. It designs, develops, manufactures and commercializes energy-based, minimally-invasive surgical aesthetic and medical treatment solutions. The Company’s proprietary technologies are used by physicians to remodel subdermal adipose, or fatty, tissue in a variety of procedures including fat reduction with simultaneous skin tightening, face and body contouring and ablative skin rejuvenation treatments. Its products target a wide array of procedures including simultaneous fat killing and skin tightening, permanent hair reduction, skin appearance and texture, among others. The Company’s products may be used on a variety of body parts, including the face, neck, abdomen, upper arms, thighs and intimate feminine regions. It owns six product platforms: BodyTite, Optimas, Votiva, Contoura, Triton and EmbraceRF. All are market and sell traditionally to plastic and facial surgeons, aesthetic surgeons and dermatologists, among others.
- Revenue in USD (TTM)287.75m
- Net income in USD127.58m
- Incorporated2008
- Employees311.00
- LocationInmode LtdTavor Building, Sha'ar Yokneam, Pob 533YOKNEAM 2069200IsraelISR
- Phone+972 49097470
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Premier Inc | 1.72bn | 260.84m | 4.87bn | 2.60k | 16.68 | 2.18 | 11.45 | 2.83 | 2.38 | 2.38 | 14.64 | 18.20 | 0.5319 | 7.15 | 4.53 | 661,981.60 | 9.41 | 15.80 | 11.58 | 19.54 | 48.65 | 64.20 | 17.70 | 31.72 | 0.8453 | 15.07 | 0.1767 | 5.99 | 32.44 | 8.16 | -56.39 | -20.44 | 2.91 | -- |
| ICU Medical Inc | 1.28bn | 103.26m | 4.89bn | 7.90k | 48.35 | 3.14 | 25.62 | 3.82 | 4.77 | 4.77 | 59.04 | 73.43 | 0.6984 | 2.60 | 8.03 | 161,866.00 | 5.64 | 5.28 | 6.62 | 6.07 | 36.76 | 37.99 | 8.07 | 6.28 | 3.67 | 1,172.47 | 0.0019 | 0.00 | 0.3788 | 30.05 | -14.02 | 14.07 | 48.43 | -- |
| Pacific Biosciences of California Inc | 105.83m | -77.21m | 5.09bn | 412.00 | -- | 19.70 | -- | 48.10 | -0.4648 | -0.4648 | 0.5389 | 1.30 | 0.145 | 3.49 | 6.77 | 256,856.80 | -10.58 | -37.11 | -12.03 | -46.53 | 42.71 | 39.54 | -72.96 | -74.86 | 25.78 | -22.21 | 0.7762 | -- | -13.20 | -3.19 | 134.95 | -- | -19.16 | -- |
| Helen of Troy Limited | 2.16bn | 214.61m | 5.50bn | 1.77k | 26.31 | 4.33 | 21.87 | 2.54 | 8.66 | 8.66 | 87.50 | 52.60 | 0.946 | 2.54 | 5.21 | 1,223,043.00 | 9.38 | 9.55 | 12.36 | 11.73 | 43.86 | 42.29 | 9.92 | 10.48 | 0.8082 | 22.99 | 0.2714 | -- | 22.92 | 8.55 | 58.79 | 21.34 | 42.70 | -- |
| Warby Parker Inc | -100.00bn | -100.00bn | 5.72bn | 1.75k | -- | -- | -- | -- | -- | -- | -- | 2.64 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 2.84 | -- | 0.00 | -- | 6.28 | -- | 2.81 | -- | -- | -- |
| Novanta Inc (USA) | 620.53m | 43.89m | 5.80bn | 2.20k | 133.26 | 11.77 | 69.81 | 9.35 | 1.23 | 1.23 | 17.35 | 13.89 | 0.7137 | 3.54 | 6.96 | 282,060.90 | 5.05 | 6.44 | 5.92 | 7.67 | 42.30 | 42.06 | 7.07 | 7.96 | 1.90 | 8.91 | 0.2869 | 0.00 | -5.67 | 9.59 | 9.19 | 4.56 | 13.64 | -- |
| STAAR Surgical Company | 206.20m | 20.78m | 5.98bn | 575.00 | 298.11 | 25.48 | 248.00 | 29.00 | 0.4232 | 0.4232 | 4.21 | 4.95 | 0.8047 | 2.91 | 4.68 | 358,605.20 | 8.11 | 2.43 | 9.46 | 3.04 | 76.39 | 72.79 | 10.08 | 2.67 | 5.56 | 54.59 | 0.0059 | 0.00 | 8.84 | 16.21 | -57.91 | -- | 32.67 | -- |
| MSA Safety Inc | 1.34bn | 101.83m | 6.03bn | 4.80k | 59.46 | 7.20 | 41.52 | 4.49 | 2.59 | 2.59 | 34.11 | 21.44 | 0.7224 | 3.33 | 5.75 | 279,657.70 | 5.54 | 6.51 | 6.66 | 7.85 | 43.14 | 44.93 | 7.67 | 8.10 | 1.69 | 11.45 | 0.2827 | 55.97 | -3.83 | 3.58 | -11.92 | 11.62 | 6.18 | 6.13 |
| Coherent, Inc. | 1.41bn | -120.12m | 6.21bn | 4.88k | -- | 7.39 | -- | 4.39 | -4.95 | -4.95 | 57.72 | 34.21 | 0.7778 | 2.05 | 6.22 | 289,752.80 | -6.61 | 2.27 | -8.01 | 2.69 | 38.22 | 40.35 | -8.50 | 2.94 | 2.03 | 13.98 | 0.3516 | 0.00 | -14.09 | 8.90 | -869.42 | -- | 23.98 | -- |
| Envista Holdings Corp | 2.82bn | 305.80m | 6.25bn | 12.40k | 22.29 | 1.61 | 14.35 | 2.21 | 1.74 | 1.74 | 16.21 | 24.00 | 0.4293 | 4.22 | 8.53 | 227,588.70 | 4.65 | -- | 5.49 | -- | 55.68 | 56.03 | 10.84 | 7.57 | 0.8513 | 6.40 | 0.2536 | 0.00 | -17.07 | -3.57 | -84.70 | -34.47 | -- | -- |
| Inmode Ltd | 287.75m | 127.58m | 6.41bn | 311.00 | 56.06 | 19.36 | 50.06 | 22.28 | 1.50 | 1.50 | 3.38 | 4.34 | 0.9267 | 2.54 | 21.43 | 925,241.20 | 41.10 | -- | 46.32 | -- | 85.14 | -- | 44.35 | -- | 8.49 | -- | 0.00 | -- | 31.81 | -- | 22.71 | -- | -- | -- |
| Stevanato Group SpA | 834.92m | 125.20m | 6.73bn | 4.34k | 59.91 | 19.04 | 37.31 | 8.07 | 0.4247 | 0.4247 | 2.83 | 1.34 | -- | -- | -- | 192,200.20 | -- | -- | -- | -- | 30.63 | -- | 15.02 | -- | 1.12 | 36.11 | 0.5114 | -- | 23.39 | -- | 100.28 | -- | -- | -- |
| Inspire Medical Systems Inc | 175.16m | -47.17m | 7.00bn | 317.00 | -- | 31.81 | -- | 39.95 | -1.74 | -1.74 | 6.48 | 8.07 | 0.6446 | 2.22 | 9.97 | 552,561.50 | -17.36 | -- | -18.64 | -- | 85.23 | 82.51 | -26.93 | -50.62 | 9.70 | -24.71 | 0.1016 | -- | 40.62 | 70.48 | -72.08 | -- | 47.98 | -- |
| Shockwave Medical Inc | 130.11m | -52.83m | 7.46bn | 449.00 | -- | 35.79 | -- | 57.34 | -1.53 | -1.53 | 3.76 | 5.93 | 0.4616 | 0.9928 | 8.31 | 289,786.20 | -18.74 | -- | -20.72 | -- | 77.27 | -- | -40.60 | -- | 5.65 | -6.83 | 0.0753 | -- | 57.92 | -- | -28.55 | -- | -- | -- |
| Globus Medical Inc | 927.90m | 184.05m | 7.90bn | 2.20k | 43.35 | 4.81 | 31.16 | 8.51 | 1.81 | 1.81 | 9.10 | 16.27 | 0.5631 | 1.04 | 6.23 | 421,774.10 | 11.17 | 10.44 | 12.03 | 11.34 | 74.48 | 75.86 | 19.83 | 18.26 | 5.08 | -- | 0.00 | 0.00 | 0.4678 | 7.69 | -34.10 | -1.94 | 4.63 | -- |
| Tandem Diabetes Care Inc | 604.84m | 6.56m | 8.03bn | 1.50k | 1,268.42 | 23.17 | 403.58 | 13.28 | 0.1004 | 0.1004 | 9.60 | 5.50 | 0.857 | 4.39 | 9.66 | 403,229.30 | 0.929 | -33.59 | 1.10 | -45.21 | 53.17 | 49.50 | 1.08 | -31.52 | 5.81 | 1.50 | 0.4478 | -- | 37.68 | 46.93 | -38.90 | -- | 41.15 | -- |
Data as of Oct 22 2021. Currency figures normalised to Inmode Ltd's reporting currency: US Dollar USD
21.04%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Acadian Asset Management LLCas of 30 Jun 2021 | 1.58m | 4.13% |
| Menora Mivtachim Insurance Ltd.as of 30 Jun 2021 | 1.06m | 2.77% |
| Van Berkom & Associates, Inc.as of 30 Jun 2021 | 916.75k | 2.40% |
| William Blair Investment Management LLCas of 30 Jun 2021 | 849.69k | 2.23% |
| Lord, Abbett & Co. LLCas of 30 Jun 2021 | 693.65k | 1.82% |
| Renaissance Technologies LLCas of 30 Jun 2021 | 688.28k | 1.80% |
| Fidelity Management & Research Co. LLCas of 30 Jun 2021 | 610.98k | 1.60% |
| Marshall Wace Asia Ltd.as of 30 Jun 2021 | 565.22k | 1.48% |
| Aberdeen Standard Investments, Inc.as of 30 Jun 2021 | 539.16k | 1.41% |
| Two Sigma Advisers LPas of 30 Jun 2021 | 534.70k | 1.40% |
More ▼
Data from 30 Jun 2021 - 30 Jun 2021Source: FactSet Research Systems Inc.
